| TLR2 agonistic small molecules: detailed structure–activity relationship, applications, and future prospects A Kaur, D Kaushik, S Piplani, SK Mehta, N Petrovsky, DB Salunke Journal of Medicinal Chemistry 64 (1), 233-278, 2020 | 34 | 2020 |
| Niosomes as efficient drug delivery modules for encapsulation of Toll-like receptor 7 agonists and IDO-inhibitor J Rathee, R Kanwar, D Kaushik, DB Salunke, SK Mehta Applied Surface Science 505, 144078, 2020 | 27 | 2020 |
| Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles D Kaushik, A Kaur, N Petrovsky, DB Salunke RSC Medicinal Chemistry 12 (7), 1065-1120, 2021 | 22 | 2021 |
| BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant D Kaushik, S Dhingra, MT Patil, S Piplani, V Khanna, Y Honda-Okubo, ... Human Vaccines & Immunotherapeutics 16 (8), 1989-1996, 2020 | 22 | 2020 |
| Efficacy of TLR7 agonistic imidazoquinoline as immunochemotherapeutic agent against P. Berghei ANKA infected rodent host R Saroa, D Kaushik, U Bagai, S Kaur, DB Salunke Bioorganic & Medicinal Chemistry Letters 29 (9), 1099-1105, 2019 | 16 | 2019 |
| Combined delivery of TLR2 and TLR7 agonists by Nanostructured lipid carriers induces potent vaccine adjuvant activity in mice A Kaur, R Kanwar, D Kaushik, IG Sakala, Y Honda-Okubo, N Petrovsky, ... International Journal of Pharmaceutics 613, 121378, 2022 | 12 | 2022 |
| Stereoisomeric Pam 2 CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants A Kaur, S Piplani, D Kaushik, J Fung, IG Sakala, Y Honda-Okubo, ... RSC Medicinal Chemistry 13 (5), 622-637, 2022 | 9 | 2022 |
| Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent D Kaushik, JT Granato, GC Macedo, PRB Dib, S Piplani, J Fung, ... Journal of Pharmacy and Pharmacology 73 (9), 1180-1190, 2021 | 8 | 2021 |
| TLR2 agonistic lipopeptide enriched PLGA nanoparticles as combinatorial drug delivery vehicle A Kaur, J Rathee, R Kanwar, D Kaushik, DB Salunke, SK Mehta Colloids and Surfaces A: Physicochemical and Engineering Aspects 647, 129084, 2022 | 6 | 2022 |
| Synthesis of quinoline based molecular probes for detection of nitric oxide D Kaushik, M Kaur, V Mutreja, K Pathania, DB Salunke, SC Sahoo, ... Dyes and Pigments 201, 110226, 2022 | 6 | 2022 |
| Polymeric nanoparticles as a promising drug delivery platform for the efficacious delivery of toll-like receptor 7/8 agonists and IDO-inhibitor J Rathee, A Kaur, R Kanwar, D Kaushik, R Kumar, DB Salunke, SK Mehta Colloids and Surfaces A: Physicochemical and Engineering Aspects 632, 127764, 2022 | 5 | 2022 |
| Structure–Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist D Kaushik, A Kaur, MT Patil, B Sihag, S Piplani, I Sakala, Y Honda-Okubo, ... Journal of Medicinal Chemistry, 2024 | 4 | 2024 |
| Synthesis of Triazolo[4′,5′:4,5]furo[2,3-c]pyridine via Post Modification of an Unusual Groebke–Blackburn–Bienaymé Multicomponent Reaction A Batra, M Kaur, D Kaushik, S Kaur, MT Patil, VD Chaudhari, SC Sahoo, ... ACS omega, 2024 | | 2024 |
| Pure TLR 7 Agonistic BBIQ is a Potential Adjuvant Against Plasmodium berghei ANKA Challenge In Vivo R Saroa, D Kaushik, A Rakha, U Bagai, S Kaur, DB Salunke Drug Development for Malaria: Novel Approaches for Prevention and Treatment …, 2022 | | 2022 |
| Process Optimization of 1-Benzyl-2-Butyl-1H-imidazo [4, 5-C] quinolin-4-Amine, a Pure TLR7 Agonist and its Demonstration as Influenza Vaccine Adjuvant D Kaushik, D Salunke Proceedings of International Conference on Drug Discovery (ICDD), 2020 | | 2020 |
Deepak B. SalunkeAssistant Professor, Panjab University, Chandigarh在 pu.ac.in 的电子邮件经过验证
